Seagen Inc (SGEN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Roger D. Dansey
Employees:
2,680
21823 30TH DRIVE SE, SUITE, BOTHELL, WA, 98021
4255274000

Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate, PADCEV, and TUKYSA. It also develops TIVDAK for metastatic cervical cancer and other solid tumors.

Data derived from most recent annual or quarterly report
Market Cap 28.059 Billion Shares Outstanding184.076 Million Avg 30-day Volume 1.159 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.61
Price to Revenue160.1103 Debt to Equity0.0 EBITDA-649.912 Million
Price to Book Value11.1097 Operating Margin-361.7643 Enterprise Value30.732 Billion
Current Ratio4.566 EPS Growth-2.21 Quick Ratio3.761
1 Yr BETA 0.8085 52-week High/Low 192.79 / 105.43 Profit Margin-363.5343
Operating Cash Flow Growth-172.4468 Altman Z-Score27.4309 Free Cash Flow to Firm -658.164 Million
Earnings Report2022-10-27
View SEC Filings from SGEN instead.

View recent insider trading info

Funds Holding SGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SGEN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-26:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-06-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-23:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-19:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-15:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    28.7 Thousand total shares from 21 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SIMPSON TODD E CHIEF FINANCIAL OFFICER

    • Officer
    137,185 2022-08-31 7

    LIU JEAN I CHIEF LEGAL OFFICER

    • Officer
    84,390 2022-08-31 8

    HIMES VAUGHN B CHIEF TECHNICAL OFFICER

    • Officer
    186,654 2022-08-31 10

    DANSEY ROGER D INTERIM CEO & CMO

    • Officer
    97,539 2022-08-31 8

    ROMP CHARLES R EVP, COMMERCIAL

    • Officer
    59,604 2022-08-31 7

    BAKER BROS. ADVISORS LP

    BAKER BROTHERS LIFE SCIENCES LP

    667, L.P.

    BAKER JULIAN

    BAKER FELIX

    BAKER BROS. ADVISORS (GP) LLC

    • Director
    • 10% Owner
    47,082,225 2022-05-13 3

    LOVE TED W

    • Director
    8,380 2022-05-13 1

    GRYSKA DAVID W

    • Director
    51,429 2022-05-13 5

    WELCH DANIEL G

    • Director
    47,110 2022-05-13 2

    SIMONIAN NANCY A

    • Director
    57,679 2022-05-13 2

    ORWIN JOHN A

    • Director
    32,679 2022-05-13 1

    SETH ALPNA

    • Director
    16,629 2022-05-13 1

    SIEGALL CLAY B PRESIDENT & CEO

    • Officer
    • Director
    717,189 2022-05-12 9

    LIPPMAN MARC E

    • Director
    57,202 2021-05-14 0

    AKKARAJU SRINIVAS

    • Director
    41,503 2020-05-15 0

    TAYLOR ROBIN G CHIEF COMMERCIAL OFFICER

    • Officer
    33,025 2019-12-19 0

    CLINE DARREN S EVP, COMMERCIAL

    • Officer
    72,556 2018-11-29 0

    DRACHMAN JONATHAN G SEE REMARKS

    • Officer
    0 2018-03-20 0

    DOBMEIER ERIC CHIEF OPERATING OFFICER

    • Officer
    119,860 2017-12-04 0

    MCLAUGHLIN JOHN PETER

    • Director
    39,400 2016-05-20 0

    FBB3 LLC

    • Director
    • 10% Owner
    12,678 2014-12-09 0

    BAKER FELIX

    BAKER JULIAN

    BAKER BROS. ADVISORS (GP) LLC

    BAKER BROS. ADVISORS LP

    667, L.P.

    BAKER BROTHERS LIFE SCIENCES LP

    14159, L.P.

    • Director
    • 10% Owner
    21,217,270 2014-12-08 0

    BOERNER CHRISTOPHER S. EXECUTIVE VICE PRESIDENT, COMM

    • Officer
    72,358 2014-08-24 0

    BERGER FRANKLIN M

    • Director
    204,720 2014-02-21 0

    BAKER BROS. ADVISORS (GP) LLC

    • Director
    • 10% Owner
    0 2013-07-01 0

    BAKER FELIX

    667, L.P.

    BAKER BROTHERS LIFE SCIENCES LP

    14159, L.P.

    BAKER JULIAN

    BAKER BROS ADVISORS LLC

    • Director
    • 10% Owner
    19,487,448 2013-05-17 0

    BAKER BROTHERS LIFE SCIENCES LP

    • Director
    15,131,223 2013-05-17 0

    14159, L.P.

    • Director
    323,148 2013-05-17 0

    667, L.P.

    • Director
    3,868,576 2013-05-17 0

    REYNOLDS THOMAS C CHIEF MEDICAL OFFICER

    • Officer
    57,601 2013-01-25 0

    FBB2 LLC

    • Director
    • 10% Owner
    18,243 2012-06-15 0

    ROSENBERG MORRIS EVP, PROCESS SCIENCES

    • Officer
    17,643 2012-06-12 0

    BAKER FELIX

    • Director
    • 10% Owner
    0 2012-05-18 0

    BAKER BROS ADVISORS LLC

    • Director
    • 10% Owner
    0 2012-04-12 0

    BAKER BIOTECH CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    4,966,001 2011-12-30 0

    BAKER BROS. CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    539,130 2011-12-30 0

    BAKER / TISCH CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    450,461 2011-12-30 0

    BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    15,131,223 2011-12-30 0

    14159 CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • Director
    • 10% Owner
    323,148 2011-09-06 0

    SEELEY BRUCE J. EVP, COMMERICAL

    • Officer
    18,861 2011-08-19 0

    HOTH DANIEL FLOYD JR

    • Director
    0 2010-05-21 0

    JP MORGAN PARTNERS BHCA LP

    JPMP MASTER FUND MANAGER L P

    JPMP CAPITAL CORP

    JP MORGAN PARTNERS GLOBAL INVESTORS LP

    J P MORGAN PARTNERS GLOBAL INVESTORS A LP

    J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP

    J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP

    JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP

    JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P

    JPMP GLOBAL INVESTORS L P

    • 10% Owner
    No longer subject to file 2008-07-28 0

    H&Q HOLDINGS, INC.

    H&Q EMPLOYEE VENTURE FUND 2000, L.P.

    • 10% Owner
    No longer subject to file 2008-07-28 0

    JP MORGAN PARTNERS BHCA LP

    • 10% Owner
    No longer subject to file 2008-05-15 0

    JP MORGAN PARTNERS BHCA LP

    JPMP MASTER FUND MANAGER L P

    JPMP CAPITAL CORP

    JP MORGAN PARTNERS GLOBAL INVESTORS LP

    J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP

    J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP

    JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP

    • Director
    • 10% Owner
    5,330,500 2007-07-09 0

    TRAILSMITH PAMELA A CHIEF SCIENTIFIC OFFICER

    • Officer
    151,357 2007-05-17 0

    DELPHI MANAGEMENT PARTNERS VI LLC

    DELPHI VENTURES VI LP

    DELPHI BIOINVESTMENTS VI LP

    • 10% Owner
    3,980,200 2007-01-17 0

    GALLEN JONATHAN

    • 10% Owner
    5,308,300 2007-01-03 0

    JP MORGAN PARTNERS BHCA LP

    JPMP MASTER FUND MANAGER L P

    JPMP CAPITAL CORP

    JP MORGAN PARTNERS GLOBAL INVESTORS LP

    J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP

    J P MORGAN PARTNERS GLOBAL INVESTORS A LP

    J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP

    JPMP GLOBAL FUND BILL BARRETT SELLDOWN LP

    JPMP GLOBAL INVESTORS L P

    • 10% Owner
    7,542,500 2006-05-19 0

    SOUTHERN DOUGLAS

    • Director
    10,000 2006-05-19 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

    2022-09-01 18:09:56 -0400 2022-08-31 S 2,064 $154.42 d 137,185 direct yes -2.1793 0.0 1 -2.1793 2

    SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

    2022-09-01 18:09:56 -0400 2022-08-31 S 2,122 $154.42 d 139,249 direct yes -2.1793 0.0 1 -2.1793 2

    HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

    2022-09-01 18:07:11 -0400 2022-08-31 S 1,789 $154.42 d 67,183 direct yes -2.1793 0.0 1 -2.1793 2

    HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

    2022-09-01 18:07:11 -0400 2022-08-31 S 1,795 $154.42 d 68,972 direct yes -2.1793 0.0 1 -2.1793 2

    ROMP CHARLES R - Officer EVP, COMMERCIAL

    2022-09-01 18:06:46 -0400 2022-08-31 S 555 $154.42 d 59,604 direct yes -2.1793 0.0 1 -2.1793 2

    ROMP CHARLES R - Officer EVP, COMMERCIAL

    2022-09-01 18:06:46 -0400 2022-08-31 S 578 $154.42 d 60,159 direct yes -2.1793 0.0 1 -2.1793 2

    LIU JEAN I - Officer CHIEF LEGAL OFFICER

    2022-09-01 18:03:28 -0400 2022-08-31 S 1,893 $154.42 d 84,390 direct yes -2.1793 0.0 1 -2.1793 2

    LIU JEAN I - Officer CHIEF LEGAL OFFICER

    2022-09-01 18:03:28 -0400 2022-08-31 S 1,755 $154.42 d 86,283 direct yes -2.1793 0.0 1 -2.1793 2

    DANSEY ROGER D - Officer INTERIM CEO & CMO

    2022-09-01 18:03:49 -0400 2022-08-31 S 4,029 $154.42 d 97,539 direct yes -2.1793 0.0 1 -2.1793 2

    DANSEY ROGER D - Officer INTERIM CEO & CMO

    2022-09-01 18:03:49 -0400 2022-08-31 S 184 $154.42 d 101,568 direct yes -2.1793 0.0 1 -2.1793 2

    DANSEY ROGER D - Officer INTERIM CEO & CMO

    2022-09-01 18:03:49 -0400 2022-08-31 S 806 $154.42 d 101,752 direct yes -2.1793 0.0 1 -2.1793 2

    SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

    2022-08-17 21:19:05 -0400 2022-08-16 S 861 $170.22 d 142,477 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

    2022-08-17 21:19:05 -0400 2022-08-16 S 1,106 $170.22 d 141,371 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    ROMP CHARLES R - Officer EVP, COMMERCIAL

    2022-08-17 21:16:29 -0400 2022-08-16 S 988 $170.22 d 60,737 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    ROMP CHARLES R - Officer EVP, COMMERCIAL

    2022-08-17 21:16:29 -0400 2022-08-16 S 777 $170.22 d 61,725 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    LIU JEAN I - Officer CHIEF LEGAL OFFICER

    2022-08-17 21:14:26 -0400 2022-08-16 S 717 $170.22 d 88,038 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    LIU JEAN I - Officer CHIEF LEGAL OFFICER

    2022-08-17 21:14:26 -0400 2022-08-16 S 922 $170.22 d 88,755 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

    2022-08-17 21:13:18 -0400 2022-08-16 S 869 $170.22 d 70,767 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

    2022-08-17 21:13:18 -0400 2022-08-16 S 658 $170.22 d 71,636 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    DANSEY ROGER D - Officer INTERIM CEO & CMO

    2022-08-17 21:12:11 -0400 2022-08-16 S 1,848 $170.22 d 102,558 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    DANSEY ROGER D - Officer INTERIM CEO & CMO

    2022-08-17 21:12:11 -0400 2022-08-16 S 2,406 $170.22 d 104,406 direct yes 1.5258 -2.7914 1.5258 2 -3.2704 4

    DANSEY ROGER D - Officer INTERIM CEO & CMO

    2022-08-17 21:12:11 -0400 2022-08-15 A 44,625 a 106,812 direct 1.5258 -2.7914 1.5258 2 -3.2704 4

    SIMPSON TODD E - Officer CHIEF FINANCIAL OFFICER

    2022-08-17 21:19:05 -0400 2022-08-15 A 15,447 a 143,338 direct 1.5258 -2.7914 1.5258 2 -3.2704 4

    ROMP CHARLES R - Officer EVP, COMMERCIAL

    2022-08-17 21:16:29 -0400 2022-08-15 A 13,731 a 62,502 direct 1.5258 -2.7914 1.5258 2 -3.2704 4

    LIU JEAN I - Officer CHIEF LEGAL OFFICER

    2022-08-17 21:14:26 -0400 2022-08-15 A 13,731 a 89,677 direct 1.5258 -2.7914 1.5258 2 -3.2704 4

    HIMES VAUGHN B - Officer CHIEF TECHNICAL OFFICER

    2022-08-17 21:13:18 -0400 2022-08-15 A 12,014 a 72,294 direct 1.5258 -2.7914 1.5258 2 -3.2704 4

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SEAGEN INC SGEN 2022-09-08 15:15:04 UTC 2.0396 0.2804 2900000
    SEAGEN INC SGEN 2022-09-08 14:45:03 UTC 2.0396 0.2804 2900000
    SEAGEN INC SGEN 2022-09-08 14:15:03 UTC 2.0396 0.2804 2900000
    SEAGEN INC SGEN 2022-09-08 13:45:03 UTC 1.9119 0.4081 2900000
    SEAGEN INC SGEN 2022-09-08 13:15:03 UTC 1.9119 0.4081 2900000
    SEAGEN INC SGEN 2022-09-08 12:45:03 UTC 1.9119 0.4081 2900000
    SEAGEN INC SGEN 2022-09-07 22:15:05 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 21:45:05 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 21:15:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 20:45:03 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 20:15:05 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 19:45:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 19:15:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 18:45:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 18:15:05 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 17:45:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 17:15:05 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 16:45:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 16:15:04 UTC 1.9119 0.4081 3000000
    SEAGEN INC SGEN 2022-09-07 15:45:04 UTC 1.9119 0.4081 3000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund SGEN -22.0 shares, $-4305.18 2020-09-30 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund SGEN -21.0 shares, $-4109.49 2020-09-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF SGEN -453.0 shares, $-61463.04 2022-05-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund SGEN -35136.0 shares, $-4603167.36 2022-04-30 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund SGEN -4225.0 shares, $-553517.25 2022-04-30 N-PORT
    PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments SGEN -3754.0 shares, $-491811.54 2022-04-30 N-PORT
    Principal Funds, Inc- Global Multi-Strategy Fund SGEN 2025.0 shares, $-274752.0 2022-05-31 N-PORT
    GMO TRUST- GMO Strategic Opportunities Allocation Fund SGEN -2000.0 shares, $-271360.0 2022-05-31 N-PORT
    GMO TRUST- GMO Benchmark-Free Fund SGEN -14500.0 shares, $-1967360.0 2022-05-31 N-PORT
    GMO TRUST- GMO Implementation Fund SGEN -44400.0 shares, $-6024192.0 2022-05-31 N-PORT
    GMO TRUST- GMO Alternative Allocation Fund SGEN -2700.0 shares, $-366336.0 2022-05-31 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund SGEN -451.0 shares, $-79799.94 2022-06-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund SGEN -1645.0 shares, $-291066.3 2022-06-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SGEN -9100.0 shares, $-1610154.0 2022-06-30 N-PORT

    Elevate your investments